Name
Kinins
Accession Number
DBCAT001752
Description

A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588)

Drugs
DrugDrug Description
IcatibantA bradykinin B2 receptor antagonist used to treat acute episodes of swelling and inflammation associated with hereditary angioedema (HAE).
LabradimilInvestigated for use/treatment in brain cancer and pediatric indications.
BradykininBradykinin has been investigated for the basic science and treatment of Hypertension and Diabetes Type 2.
Sar9, Met (O2)11-Substance PInvestigated for use/treatment in acute respiratory distress syndrome (ARDS) and viral infection.
Drugs & Drug Targets
DrugTargetType
IcatibantB2 bradykinin receptortarget
IcatibantAminopeptidase Ntarget
LabradimilB2 bradykinin receptortarget
Sar9, Met (O2)11-Substance PCytochrome P450 19A1enzyme
Sar9, Met (O2)11-Substance PCholinesteraseenzyme
Sar9, Met (O2)11-Substance PProstaglandin G/H synthase 2enzyme